| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.7 |